NVCR Announces Positive Phase 2 PANOVA-4 Trial Topline Results for Metastatic Pancreatic Cancer Therapy
NovoCure Limited Ordinary Shares · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $16.56
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS